Aminopyridine derivatives as mGluR5 antagonists
US7205411B2 · kind B2 · utility
4Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2005 |
| Grant date | Apr 17, 2007 |
| Priority date | — |
| Expiry date | Oct 11, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel aminopyridine derivatives of formula (I) wherein R1 is methyl an R4 and amino group —NR6R7 and R5 forms an arylalkynyl- or heteroarylalkynyl-group. The compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.